We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YETI:NYSEYETI Holdings, Inc. Analysis

Data as of 2026-05-12 - not real-time

$40.92

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

YETI trades around $40.9, roughly double the DCF‑derived fair value of $20.9, indicating the market is pricing significant growth expectations into the stock. YETI posted $1.87 B in revenue with 6.8% YoY growth, confirming top‑line momentum. Operating margin of 12.7% and free cash flow of $90.6 M demonstrate solid profitability. A forward PE of 12.6 versus trailing PE of 20.2 underscores expected earnings acceleration. The balance sheet shows modest net debt (debt‑to‑equity 35%) and ample cash, keeping financial risk low. Analyst consensus of 15 “Buy” recommendations and a median price target of $53 imply upside of roughly 23% from current levels.
Technically, the 20‑day SMA ($40.10) sits just below price, while the 50‑day SMA ($38.71) remains supportive, indicating a neutral to slightly bullish bias. MACD is bullish with the line above the signal, and the histogram is positive. RSI at 55 suggests the stock is not overbought. Volume trend is decreasing, which could limit short‑term momentum. Beta of 1.7 and 30‑day volatility of 46% point to heightened price swings. Combined with an “Extreme Greed” market sentiment, the stock appears positioned for a breakout but with notable risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and neutral RSI
  • Decreasing volume limiting momentum
  • High beta and volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus buy and 23% upside target
  • Strong revenue growth and improving margins
  • Robust free cash flow generation

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Brand strength and premium positioning
  • Valuation gap between price and DCF fair value
  • Sustainable cash flow and manageable debt

Key Metrics & Analysis

Financial Health

Revenue Growth6.80%
Profit Margin8.85%
P/E Ratio20.2
ROE23.79%
ROA10.59%
Debt/Equity35.13
P/B Ratio4.7
Op. Cash Flow$254.7M
Free Cash Flow$90.6M

Technical Analysis

TrendNeutral
RSI54.7
Support$36.91
Resistance$43.54
MA 20$40.10
MA 50$38.71
MA 200$39.50
MACDBullish
VolumeDecreasing
Fear & Greed Index88.61

Valuation

Fair Value$20.88
Target Price$50.47
Upside/Downside23.33%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.74
Volatility46.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.